Delivery Order SPE2DB20D3103-SPE2DB25FQ5B8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel (100 grams) with a ceiling value of $1,242.72 on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-competitive delivery order employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction supporting the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Diclofenac Sodium 1% Gel in 100-gram units, with a ceiling value of $1,173.12. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel (100GM) with a ceiling value of $1,466.40. This non-competitive, firm fixed-price delivery order was executed on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.56 to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram quantities. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Diclofenac Sodium 1% Gel in 100-gram units, with a ceiling value of $1,645.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is...
- The Defense Logistics Agency awarded a $1,613.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram units, with an ultimate completion date of September 22, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.56 to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel in 100-gram quantities. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award authority. The delivery order is set to complete by September 19, 2025, one day after the award date of September 18, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Diclofenac Sodium 1% Gel 100GM valued at $3,276.00. This firm fixed price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 18, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,466.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel 100GM, a nonsteroidal anti-inflammatory topical medication. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 29, 2025. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a $1,363.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 grams of Diclofenac Sodium 1% Gel, a topical anti-inflammatory medication. The award is not set aside and has an ultimate completion date of June 26, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ5B8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,745.04 to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel (100gm) on September 27, 2025, with completion scheduled for September 29, 2025. This firm fixed-price delivery order is a non-set-aside award and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to federal military and veteran healthcare systems. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Diclofenac Sodium, a nonsteroidal anti-inflammatory drug, represents the type of pain management pharmaceutical included within the contract's extensive therapeutic portfolio serving Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/27/25 |